The Minister of Health presides over the General Assembly of Vaxira
Dr. Khaled Abdel -Ghaffar, Deputy Prime Minister and Minister of Health and Population, and President of the General Assembly of Vaxira, presided over the social and unusual general assembly of the Holding Company for Biomedics and Vaccines & Laquo; Paxira & RAKUO; in order to ratify the financial lists of the company’s budget, and review future investment plans.
Dr. Hossam Abdel Ghaffar explained the spokesman The official of the Ministry of Health and Population, that after the completion of the quorum, in the presence of all members of the Board of Directors, the ratification of the actual financial statements assembled for the holding company and its subsidiary companies was discussed, as well as the ratification of the Board of Directors report on the results of the financial years of the years 2022-2025, where the results of the financial work of the holding company for that period reached 394 million, 582 thousand and 339 pounds, while the results of the business group’s economic business and its subsidiary companies reached For 2 billion and 532 million and 791 thousand and 42 pounds. Until the minister reviewed during the meeting the results of the work of the committees that were directed to form it at the regular general assembly meeting in the month of December 2023, which included a technical committee, the Evaluation Committee for the Holding Company’s performance and its subsidiary companies, and the Research and Development Committee, where the committees’ meetings witnessed the development and improvement of vaccine production, the resettlement of the vaccine industry, the overcoming obstacles in providing the necessary financing, and cooperation with research institutions in research projects And development. The meeting discussed approval to increase the capital of the Holding Company for vital preparations and vaccines, as the minister directed to study the available investment opportunities, and to benefit in a report on them within two weeks, to study them and raise them to the competent authorities to take actual steps towards investment support, as well as studying observations to open new markets in the Arab and African countries, through the company’s committees and submit recommendations and present them to a council Administration. Until the minister listened to a detailed presentation on the future plans of & laquo & raquo; Which includes a short -term plan, included the completion of the implementation of the second and third phase of the manufacturing technology transfer agreement with the Indian Serm Company, as well as the second stage & laquo; CD Bio & raquo; Chinese, creation of central laboratories, experimental custody in the 27th building at the company’s headquarters in Agouza, to support the quality control tests, vaccines, biological preparations, and modernization of the & laquo factory; Building 2 & raquo; According to the requirements of good manufacturing and the recommendations of the World Health Organization, the exploitation of the central logistical cooling complex after its license, to store vaccines, vaccines, and medicines. Until future plans included a long -term plan that included a project to develop vaccine production & laquo; BCG & raquo; For tumors, the creation of a building to provide a variety of vaccines in 7 stages to produce 10 different vaccines, establish the Biomedical safety factory from the third level, and implement a comprehensive plan for digital transformation with the aim of enhancing efficiency and facilitating services. To start establishing a number of branches of the company in the governorates of Upper Egypt, as part of the expansion plan to increase the productive capacity, and to improve the ways to distribute vaccine and biomedical preparations. Issa, Chairman
- For more: Follow Khaleejion 24 Arabic, Khaleejion 24 English, Khaleejion 24 Live, and for social media follow us on Facebook and Related
